Atlas Trials

Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer

Clinical trial NCT01716949 · UNKNOWN

Trial details

NCT number
NCT01716949
Sponsor
University of Erlangen-Nürnberg Medical School
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2012-09-01
Primary completion
2022-06-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.